デフォルト表紙
市場調査レポート
商品コード
1411498

脳イメージングモダリティ市場:イメージングタイプ、患者タイプ、エンドユーザー別-2024-2030年の世界予測

Brain Imaging Modalities Market by Imaging Type (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET)), Patient Type (Adults & Paediatrics, Infants), End User - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 187 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
脳イメージングモダリティ市場:イメージングタイプ、患者タイプ、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 187 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

脳イメージングモダリティ市場規模は2023年に148億7,000万米ドルと推計され、2024年には160億5,000万米ドルに達し、CAGR 7.66%で2030年には249億4,000万米ドルに達すると予測されます。

脳イメージングモダリティの世界市場

主な市場の統計
基準年[2023] 148億7,000万米ドル
予測年[2024] 160億5,000万米ドル
予測年 [2030] 249億4,000万米ドル
CAGR(%) 7.66%
脳イメージングモダリティ Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは脳イメージングモダリティ市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、脳イメージングモダリティ市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1-市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1-脳イメージングモダリティ市場の市場規模および予測は?

2-脳イメージングモダリティ市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3-脳イメージングモダリティ市場における技術動向と規制の枠組みは?

4-脳イメージングモダリティ市場における主要ベンダーの市場シェアは?

5-脳イメージングモダリティ市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 脳イメージングモダリティ市場イメージングタイプ別

  • コンピュータ断層撮影(CT)
  • 磁気共鳴画像法(MRI)
  • 陽電子放出断層撮影法(PET)
  • 単一光子放射コンピュータ断層撮影法(SPECT)

第7章 脳イメージングモダリティ市場患者タイプ別

  • 成人および小児科
  • 幼児

第8章 脳イメージングモダリティ市場:エンドユーザー別

  • バイオテクノロジー企業
  • 受託調査機関(CRO)
  • 製薬会社
  • 調査機関

第9章 南北アメリカの脳イメージングモダリティ市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の脳イメージングモダリティ市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの脳イメージングモダリティ市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abbott Laboratories
    • Advantis Medical Imaging
    • AiM Medical Robotics
    • Delphinus Medical Technologies
    • Esaote SpA
    • Ezra
    • F. Hoffmann-La Roche AG
    • General Electric Company
    • Hitachi, Ltd.
    • Koninklijke Philips N.V.
    • Magnetic Insight, Inc.
    • Octave Biosciences
    • Perspectum
    • Promaxo
    • Sanrad Medical Systems Pvt. Ltd.
    • Siemens AG
    • Subtle Medical, Inc.
    • Tempus Labs, Inc.
    • Thermo Fisher Scientific Inc.
    • Toshiba Corporation
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. BRAIN IMAGING MODALITIES MARKET RESEARCH PROCESS
  • FIGURE 2. BRAIN IMAGING MODALITIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. BRAIN IMAGING MODALITIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BRAIN IMAGING MODALITIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. BRAIN IMAGING MODALITIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BRAIN IMAGING MODALITIES MARKET DYNAMICS
  • FIGURE 7. BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2023 VS 2030 (%)
  • FIGURE 8. BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
  • FIGURE 10. BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES BRAIN IMAGING MODALITIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES BRAIN IMAGING MODALITIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. BRAIN IMAGING MODALITIES MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. BRAIN IMAGING MODALITIES MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. BRAIN IMAGING MODALITIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. BRAIN IMAGING MODALITIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. BRAIN IMAGING MODALITIES MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BRAIN IMAGING MODALITIES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BRAIN IMAGING MODALITIES MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. BRAIN IMAGING MODALITIES MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. BRAIN IMAGING MODALITIES MARKET SIZE, BY ADULTS & PAEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BRAIN IMAGING MODALITIES MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. BRAIN IMAGING MODALITIES MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. BRAIN IMAGING MODALITIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION (CRO'S), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BRAIN IMAGING MODALITIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BRAIN IMAGING MODALITIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM BRAIN IMAGING MODALITIES MARKET SIZE, BY IMAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM BRAIN IMAGING MODALITIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. BRAIN IMAGING MODALITIES MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 146. BRAIN IMAGING MODALITIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. BRAIN IMAGING MODALITIES MARKET LICENSE & PRICING
目次
Product Code: MRR-5C6F41F5AFA9

[187 Pages Report] The Brain Imaging Modalities Market size was estimated at USD 14.87 billion in 2023 and expected to reach USD 16.05 billion in 2024, at a CAGR 7.66% to reach USD 24.94 billion by 2030.

Global Brain Imaging Modalities Market

KEY MARKET STATISTICS
Base Year [2023] USD 14.87 billion
Estimated Year [2024] USD 16.05 billion
Forecast Year [2030] USD 24.94 billion
CAGR (%) 7.66%
Brain Imaging Modalities Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Brain Imaging Modalities Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Brain Imaging Modalities Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Brain Imaging Modalities Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advantis Medical Imaging, AiM Medical Robotics, Delphinus Medical Technologies, Esaote SpA, Ezra, F. Hoffmann-La Roche AG, General Electric Company, Hitachi, Ltd., Koninklijke Philips N.V., Magnetic Insight, Inc., Octave Biosciences, Perspectum, Promaxo, Sanrad Medical Systems Pvt. Ltd., Siemens AG, Subtle Medical, Inc., Tempus Labs, Inc., Thermo Fisher Scientific Inc., and Toshiba Corporation.

Market Segmentation & Coverage

This research report categorizes the Brain Imaging Modalities Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Imaging Type
    • Computed Tomography (CT)
    • Magnetic Resonance Imaging (MRI)
    • Positron Emission Tomography (PET)
    • Single Photon Emission Computed Tomography (SPECT)
  • Patient Type
    • Adults & Paediatrics
    • Infants
  • End User
    • Biotech Companies
    • Contract Research Organization (CRO's)
    • Pharmaceutical Companies
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Brain Imaging Modalities Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Brain Imaging Modalities Market?

3. What are the technology trends and regulatory frameworks in the Brain Imaging Modalities Market?

4. What is the market share of the leading vendors in the Brain Imaging Modalities Market?

5. Which modes and strategic moves are suitable for entering the Brain Imaging Modalities Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Brain Imaging Modalities Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
    • 5.1.2. Restraints
    • 5.1.3. Opportunities
    • 5.1.4. Challenges
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Brain Imaging Modalities Market, by Imaging Type

  • 6.1. Introduction
  • 6.2. Computed Tomography (CT)
  • 6.3. Magnetic Resonance Imaging (MRI)
  • 6.4. Positron Emission Tomography (PET)
  • 6.5. Single Photon Emission Computed Tomography (SPECT)

7. Brain Imaging Modalities Market, by Patient Type

  • 7.1. Introduction
  • 7.2. Adults & Paediatrics
  • 7.3. Infants

8. Brain Imaging Modalities Market, by End User

  • 8.1. Introduction
  • 8.2. Biotech Companies
  • 8.3. Contract Research Organization (CRO's)
  • 8.4. Pharmaceutical Companies
  • 8.5. Research Institutes

9. Americas Brain Imaging Modalities Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Brain Imaging Modalities Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Brain Imaging Modalities Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Abbott Laboratories
    • 13.1.2. Advantis Medical Imaging
    • 13.1.3. AiM Medical Robotics
    • 13.1.4. Delphinus Medical Technologies
    • 13.1.5. Esaote SpA
    • 13.1.6. Ezra
    • 13.1.7. F. Hoffmann-La Roche AG
    • 13.1.8. General Electric Company
    • 13.1.9. Hitachi, Ltd.
    • 13.1.10. Koninklijke Philips N.V.
    • 13.1.11. Magnetic Insight, Inc.
    • 13.1.12. Octave Biosciences
    • 13.1.13. Perspectum
    • 13.1.14. Promaxo
    • 13.1.15. Sanrad Medical Systems Pvt. Ltd.
    • 13.1.16. Siemens AG
    • 13.1.17. Subtle Medical, Inc.
    • 13.1.18. Tempus Labs, Inc.
    • 13.1.19. Thermo Fisher Scientific Inc.
    • 13.1.20. Toshiba Corporation
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing